Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × LCL161 × Clear all

NCT01617668 2016-10-17

A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer

Phase 2 Completed

209 enrolled 20 charts

Breast Neoplasms, Triple Negative Breast Neoplasms